Whilst the ‘Ivy Glioblastoma Atlas’ reports comprehensive RNA-seq data for histologically defined GBM regions (including ‘Leading Edge’ and ‘Infiltrative Tumour’), insufficient survival data for patients who also had TTR, SERPINE1, ACTA2 and APOA1 expression data, precludes survival analyses for these four candidate proteins. This evidence concerns the gene SERPINE1 and neoplasm.